Metabical: pricing, packaging and demand forecasting

Group A24Pooja Sharma PGP/16/036Priyank Bavishi PGP/16/037Diksha Bajaj PGP/16/141Manoj Kumar Meena PGP/16/322Metabical: pricing, packaging and demand forecastingCurrent Weight Loss OptionsNew weight-loss drug for people with BMI between 25-30, prescription drug, high success rate in clinical trial, low dose formulation with minimal side effects and affordableMetabical TG SegmentationTwo categories to targetEnd ConsumersHealth Care ProvidersEnd Consumers Segmentation Demographic PsychographicDemographic Segmentation FactorsAge people for who health concerns of being overweight are magnified due to age Income people who have already tried expensive weight-loss methods but have failed and are ready to spend furtherEducation people rather educated so that they can ask for prescription from doctors (pull marketing) and are aware of side-effects, understand the importance of certain behavioural changes in lifestyleDemographic Segmentation AnalysisFrom Exhibit 2

Weight-Loss EffortsMen %ageWomen %ageDissatisfied with current weight 65%75%Visit health care service provider yearly30%50%Ready to change behaviour for healthy lifestyle40%55%Tried but failed to lose weight30%60%Dissatisfied with current weight-loss options65%35%Psychographic Segmentation AnalysisFrom Exhibit 3 (Females Only )

MotiveDemographic Profile(Age, Education, Income)Part of TG (Yes/No)ReasonWant to look like movie star18-30 years, High School,